Xingwei Li

Title: Innovations of Xingwei Li in Heavy Metal Chelation

Introduction

Xingwei Li is a notable inventor based in Sichuan, China. He has made significant contributions to the field of medicine and health protection through his innovative research. His work primarily focuses on developing new heavy metal chelating agents that can be administered orally.

Latest Patents

Xingwei Li holds a patent for a heavy metal chelating agent designed for oral administration. The patent, titled "Heavy metal chelating agent for oral administration, its synthesis and its uses in medicine and health protection," introduces a novel class of chelating agents. These agents, specifically NGP,I and NGCD,II, are synthesized through a reaction involving glucose and cysteine, resulting in compounds that effectively accelerate the excretion of heavy metals such as Pb, Cd, Hg, Al, Sb, and As. The advantages of these compounds include their suitability for oral use, high efficacy in heavy metal excretion, selectivity, and reduced toxicity compared to existing drugs.

Career Highlights

Xingwei Li is affiliated with the Sichuan Research Institute of Nature Drugs, where he conducts his research and development activities. His work has garnered attention for its potential applications in health and medicine, particularly in detoxifying heavy metal exposure.

Collaborations

Xingwei Li collaborates with several colleagues, including Shiqi Peng and Chao Wang, to advance his research and explore new applications for his inventions.

Conclusion

Xingwei Li's innovative work in developing heavy metal chelating agents represents a significant advancement in medical science. His contributions have the potential to improve health outcomes for individuals exposed to harmful heavy metals.